Annual report pursuant to Section 13 and 15(d)

CONDENSED CONSOLIDATED STATEMENT OF SHAREHOLDERS` EQUITY

v3.5.0.2
CONDENSED CONSOLIDATED STATEMENT OF SHAREHOLDERS` EQUITY - USD ($)
Series A Preferred Stock [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total
Balance at Oct. 31, 2014 $ 14,000 $ 87,882 $ 148,677,413 $ (144,769,722) $ 4,009,573
Balance (in Shares) at Oct. 31, 2014 140 8,788,176      
Stock option compensation to employees and consultants     2,676,309   2,676,309
Common stock issued upon exercise of stock options   $ 173 44,462   44,635
Common stock issued upon exercise of stock options (in Shares)   17,334      
Common stock issued to consultants   $ 116 45,984   46,100
Common stock issued to consultants (in Shares)   11,600      
Repurchase 92,232 shares of common stock and cancellation of warrants to purchase 16,000 shares of common stock     (343,973)   (343,973)
Retire common stock repurchased   $ (922) 922    
Retire common stock repurchased (in Shares)   (92,232)      
Net Loss       (1,379,043) (1,379,043)
Balance at Oct. 31, 2015 $ 14,000 $ 87,249 151,101,117 (146,148,765) 5,053,601
Balance (in Shares) at Oct. 31, 2015 140 8,724,878      
Stock option compensation to employees and consultants     873,561   873,561
Common stock issued upon exercise of stock options   $ 127 33,454   33,581
Common stock issued upon exercise of stock options (in Shares)   12,676      
Common stock issued to consultants   $ 108 31,252   31,360
Common stock issued to consultants (in Shares)   10,833      
Common stock issued to acquire patents   $ 40 11,760   11,800
Common stock issued to acquire patents (in Shares)   4,000      
Net Loss       (5,016,428) (5,016,428)
Balance at Oct. 31, 2016 $ 14,000 $ 87,524 $ 152,051,144 $ (151,165,193) $ 987,475
Balance (in Shares) at Oct. 31, 2016 140 8,752,387